IL138051A0 - Pharmaceutical formulation containing a hyaluronic acid-splitting enzyme of microbial origin - Google Patents

Pharmaceutical formulation containing a hyaluronic acid-splitting enzyme of microbial origin

Info

Publication number
IL138051A0
IL138051A0 IL13805199A IL13805199A IL138051A0 IL 138051 A0 IL138051 A0 IL 138051A0 IL 13805199 A IL13805199 A IL 13805199A IL 13805199 A IL13805199 A IL 13805199A IL 138051 A0 IL138051 A0 IL 138051A0
Authority
IL
Israel
Prior art keywords
hyaluronic acid
pharmaceutical formulation
formulation containing
microbial origin
splitting enzyme
Prior art date
Application number
IL13805199A
Other languages
English (en)
Original Assignee
Id Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1998160541 external-priority patent/DE19860541A1/de
Priority claimed from DE1998160542 external-priority patent/DE19860542A1/de
Application filed by Id Pharma Gmbh filed Critical Id Pharma Gmbh
Publication of IL138051A0 publication Critical patent/IL138051A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/02—Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2)
    • C12Y402/02001—Hyaluronate lyase (4.2.2.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL13805199A 1998-12-23 1999-12-22 Pharmaceutical formulation containing a hyaluronic acid-splitting enzyme of microbial origin IL138051A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998160541 DE19860541A1 (de) 1998-12-23 1998-12-23 Pharazeutische Formulierung enthaltend glycosaminoglycanspaltendes Enzym
DE1998160542 DE19860542A1 (de) 1998-12-23 1998-12-23 Hyaluronatspaltendes Enzymfragment
PCT/DE1999/004108 WO2000039290A2 (de) 1998-12-23 1999-12-22 Pharmazeutische formulierung enthaltend ein hyaluronsäure-spaltendes enzym mikrobieller herkunft

Publications (1)

Publication Number Publication Date
IL138051A0 true IL138051A0 (en) 2001-10-31

Family

ID=26051101

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13805199A IL138051A0 (en) 1998-12-23 1999-12-22 Pharmaceutical formulation containing a hyaluronic acid-splitting enzyme of microbial origin

Country Status (10)

Country Link
EP (1) EP1056839A1 (de)
JP (1) JP2002533473A (de)
KR (1) KR20010041235A (de)
AU (1) AU3032400A (de)
CA (1) CA2318356A1 (de)
DE (1) DE19982882D2 (de)
HU (1) HUP0103660A2 (de)
IL (1) IL138051A0 (de)
PL (1) PL344745A1 (de)
WO (1) WO2000039290A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19963538A1 (de) * 1999-12-22 2001-07-05 Univ Schiller Jena Verwendung eines Enzyms zur Verbesserung der Geweberesorption von Arzneimitteln
DE10103271A1 (de) * 2001-01-23 2002-07-25 Knoell Hans Forschung Ev Pharmazeutische Formulierungen zur Erweichung von Bindegewebe, insbesondere zur Formkorrektur von Bindegewebe und Bindegewebestrukturen
US7871607B2 (en) 2003-03-05 2011-01-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
NZ542873A (en) 2003-03-05 2008-07-31 Halozyme Inc Soluble, neutral-active hyaluronidase activity glycoprotein (sHASEGP) that is produced with high yield in a mammalian expression system by introducing nucleic acids that lack a narrow region encoding amino acids in the carboxy terminus of the human PH20 cDNA
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
AU2003239763A1 (en) * 2003-05-27 2005-01-04 Friedrich-Schiller- Universität Jena Hyaluronate lyase-containing agent for treating acute myocardial infarction or symptoms thereof and for the treatment of postinfarction myocarditis and myocardial ischaemia
DE102007031417A1 (de) 2007-07-04 2009-01-08 Friedrich-Schiller-Universität Jena Hyaluronatlyase mit erhöhter Wirksamkeit, insbesondere für die Herstellung von pharmazeutischen Formulierungen und Medizinprodukten, sowie deren Verwendung
CN101855248B (zh) 2007-11-13 2012-08-22 生物技术通用（以色列）有限公司 用于粘弹性生物聚合物的稀释过滤灭菌方法
EA022752B1 (ru) 2008-12-09 2016-02-29 Галозим, Инк. Длинные растворимые полипептиды рн20 и их использование

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1120298A (en) * 1966-07-11 1968-07-17 Biorex Laboratories Ltd Stabilised enzymes
US3708575A (en) * 1970-05-13 1973-01-02 Biorex Laboratories Ltd Method for the treatment of atherosclerosis employing glucuronoglycos-aminoglycan-hyaluronate-lyase
US3728223A (en) * 1971-10-08 1973-04-17 Amano Pharma Co Ltd Production of hyaluronidase from a strain of streptomyces
ATE245452T1 (de) * 1998-12-23 2003-08-15 Esparma Gmbh Hyaluronatlyase als penetrationsförderer in topischen mitteln

Also Published As

Publication number Publication date
JP2002533473A (ja) 2002-10-08
EP1056839A1 (de) 2000-12-06
KR20010041235A (ko) 2001-05-15
CA2318356A1 (en) 2000-07-06
HUP0103660A2 (hu) 2002-01-28
PL344745A1 (en) 2001-11-19
AU3032400A (en) 2000-07-31
DE19982882D2 (de) 2001-10-04
WO2000039290A2 (de) 2000-07-06
WO2000039290A8 (de) 2000-10-19
WO2000039290A3 (de) 2001-03-08

Similar Documents

Publication Publication Date Title
ZA987800B (en) Pharmaceutical composition of meloxicam
AU1875501A (en) System and method of distributing and returning products
AU9173698A (en) Microbial decontamination of food
AU6740298A (en) Pharmaceutical composition
AU5619400A (en) Statine-derived tetrapeptide inhibitors of beta-secretase
AU5419500A (en) Bacteriophage rm 378 of a thermophilic host organism
AU1574900A (en) Pharmaceutical compositions containing insulin
AU4328800A (en) Pharmaceutical formulation
AU8107998A (en) Pharmaceutical compositions
IL138051A0 (en) Pharmaceutical formulation containing a hyaluronic acid-splitting enzyme of microbial origin
AU6949200A (en) Human hydrolytic enzymes
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU9343098A (en) Pharmaceutical composition
AU6422298A (en) Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
HUP9802716A3 (en) Pharmaceutical composition of analgesic activity
AU1930097A (en) Slow-release pharmaceutical formulations containing mizolastin
AU4543500A (en) Pharmaceutical compositions and uses
IL146408A0 (en) Diphosphate salt of a 4-substituted-9-deoxo-9a-homoerythromycin derivative and its pharmaceutical composition
HUP0201880A3 (en) Pharmaceutical composition containing sibutramine and a lipase inhibitor
AU3839900A (en) Pharmaceutical formulation
AU1677100A (en) Localization of software products
AU5182099A (en) Pharmaceutical formulation
AU1567301A (en) Tablets comprising micro-organisms and method for preparation of the tablets
AU1388501A (en) Pharmaceutical formulation
AU3989100A (en) Pharmaceutical gel formulation